YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors-Reference-Cited by-同舟云学术

YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors

Published:2015-08-25 Issue:5 Volume:62 Page:1497-1510
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Marti Patricia¹,Stein Claudia¹,Blumer Tanja²,Abraham Yann¹,Dill Michael T.²,Pikiolek Monika¹,Orsini Vanessa¹,Jurisic Giorgia¹,Megel Philippe³,Makowska Zuzanna²,Agarinis Claudia¹,Tornillo Luigi⁴,Bouwmeester Tewis¹,Ruffner Heinz¹,Bauer Andreas¹,Parker Christian N.¹,Schmelzle Tobias³,Terracciano Luigi M.⁴,Heim Markus H.²,Tchorz Jan S.¹

Affiliation:

1. Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG; Basel Switzerland

2. Division of Gastroenterology and Hepatology; University Hospital Basel; Basel Switzerland

3. Novartis Institutes for Biomedical Research, Oncology, Novartis Pharma AG; Basel Switzerland

4. Institute for Pathology, University Hospital Basel; Basel Switzerland

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27992/fullpdf

Reference50 articles.

1. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma;Bridgewater;J Hepatol,2014

2. New insights on cholangiocarcinoma;Gatto;World J Gastrointest Oncol,2010

3. Cholangiocarcinoma: update and future perspectives;Gatto;Dig Liver Dis,2010

4. Cholangiocarcinoma-controversies and challenges;Patel;Nat Rev Gastroenterol Hepatol,2011

5. Cholangiocarcinoma;Razumilava;Lancet,2014

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetically Integrated Tumor–Vascular Interface System to Mimic Pro-angiogenic Endothelial Dysregulations for On-Chip Drug Testing;ACS Applied Materials & Interfaces;2024-08-28

2. Regulation of Hippo–YAP signaling axis by Isoalantolactone suppresses tumor progression in cholangiocarcinoma;Translational Oncology;2024-08

3. Transposon-based oncogene integration in Abcb4(Mdr2)-/- mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis;Journal of Hepatology;2024-07

4. Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma;Journal of Hepatology;2024-06

5. Signaling pathways in liver cancer: pathogenesis and targeted therapy;Molecular Biomedicine;2024-05-31